This project was funded by the Department of Health and Ageing under the Quality Use of Pathology Program.
The author acknowledges with sincere thanks:
Anatomical Pathology Performance Review Committee: Prof David Davies, A/Prof Glen Francis, Prof Jane Dahlstrom, Dr Fiona Maclean, Dr Adrienne Morey, Dr Michael Aldred, A/Prof Steve Farish, Dr Tamazin Leecy, Martyn Peck
Cytopathology Performance Review Committee: A/Prof Margaret Cummings, Dr David Papadimos, A/Prof Marion Saville, Dr Chris Carter, Prof Yee Khong, A/Prof Annabelle Farnsworth, Jennifer Ross.
Transfusion Advisory Committee: Dr Bronwyn Williams, Arthur Joyce, Cheryl Kann, Liz Lennox, Geoff Magrin, Dr Anne Haughton, Tony Greenfield, Neville Herrmann, Cathy Hughes.
Chemical Pathology Performance Review Committee: Dr Graham Jones, Peter Graham, Dr Penelope Coates, Dr Helen Martin, Dr Que Lam, Dr Samuel Vasikaran, Janice Gill, Lisa Jolly.
RCPA QAP Board of Directors: A/Prof Peter Stewart, Dr John Wells, Dr Lawrence Bott, Dr John Rowell, Dr Raymond Chan, Mr Mike Ralston, Dr Beverley Rowbotham.
RCPA QAP Executive Team and staff: Dr Ian Gardner, Penny Petinos, Paul Cohen, Alan Bateman, David Bryce, Moira Clarke, Glen Conboy, Marty Kopka, Jeff Hong, Nathan Crettenden, Anthony Green
National Association of Testing Authorities: Andrew Griffin
Royal College of Pathologists: Dr Debra Graves, Sue Butterworth
Therapeutic Goods Administration: Peter Kaylock
IVD Australia: Dr Peter Harman
Document download
This publication is available as a downloadable document.
The Role of External Quality Assurance in Identifying Poor Laboratory Performance(PDF 518 KB)